Skip to content
Search

Latest Stories

NHS obesity and type 2 diabetes programme helping patients lose over 8 pounds

NHS obesity and type 2 diabetes programme helping patients lose over 8 pounds
In the battle against obesity and type 2 diabetes, more than a third of the referrals for NHS's weight management programme were for people of colour

Part of a raft of National Health Services (NHS) measures which aim to support people to prevent or reduce incidence of type 2 diabetes and obesity, the NHS Digital Weight Management Programme has emerged as a beacon of success in the battle against obesity, with a recent study showcasing its effectiveness in aiding weight loss among participants.

According to research published in The Obesity Journal, the programme has garnered significant traction, with over 63,000 individuals referred in its inaugural year.


Encouragingly, half of those referred opted to enroll in the service, highlighting its appeal and accessibility.

Among the 14,000 participants who completed the 12-week programme between April 2021 and March 2022, a notable average weight loss of 3.9kg (equivalent to 8.59lbs) was achieved.

Even among those who did not complete the programme, an average weight loss of 2.2kg (approximately 4.85lbs) was observed.

One of the programme's standout features is its inclusivity, with more than a third of referrals coming from Black, Asian, and minority ethnic backgrounds. This underscores its effectiveness in addressing health disparities and supporting individuals from diverse communities.

Notably, the programme targets individuals with a body mass index (BMI) of 30 or higher, with lowered thresholds for those from minority ethnic backgrounds.

Moreover, it provides tailored interventions based on individual risk levels, offering varying degrees of support ranging from digital content to personalised coaching sessions.

Dr. Clare Hambling, NHS National Clinical Director for Diabetes and Obesity, hailed the programme's achievements, emphasising its role in leveraging existing weight management services with convenient digital access.

“While this study looked at the initial 64,000 patients referred in the programme’s first year, we have now seen more than 358,000 referrals by GPs and it’s very encouraging to see so many people benefit from the NHS Digital Weight Management Programme”.

Public Health Minister Andrea Leadsom echoed Dr. Hambling's sentiments, highlighting the programme's pivotal role in addressing the pressing issue of obesity and its associated health risks.

"We know that two thirds of adults are overweight or living with obesity, so I am delighted to see how effective the NHS Digital Weight Management Programme is in helping people living with obesity to lose weight and improve their health."

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less